GRANULES INDIA
Back to Balance Sheet
|
GRANULES INDIA Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹2,092 Cr | ₹2,003 Cr | ₹2,082 Cr | ₹1,814 Cr | ₹1,642 Cr |
What is the latest Total Current Liabilities ratio of GRANULES INDIA ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹2,092 Cr |
| Mar2025 | ₹2,003 Cr |
| Mar2024 | ₹2,082 Cr |
| Mar2023 | ₹1,814 Cr |
| Mar2022 | ₹1,642 Cr |
How is Total Current Liabilities of GRANULES INDIA Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,092 Cr | 4.44 | |
| Mar2025 | ₹2,003 Cr | -3.80 | |
| Mar2024 | ₹2,082 Cr | 14.82 | |
| Mar2023 | ₹1,814 Cr | 10.47 | |
| Mar2022 | ₹1,642 Cr | - | |
Compare Total Current Liabilities of peers of GRANULES INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GRANULES INDIA | ₹22,004.0 Cr | -0.8% | -7.3% | 46.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,684.0 Cr | -1.4% | -6.5% | 5.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹241,311.0 Cr | -2% | -2.7% | 40.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,079.0 Cr | -1.8% | -7% | 29.6% | Stock Analytics | |
| CIPLA | ₹107,528.0 Cr | 0.1% | -3% | -15.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,667.0 Cr | 0.2% | 6% | -2.4% | Stock Analytics | |
GRANULES INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GRANULES INDIA | -0.8% |
-7.3% |
46.4% |
| SENSEX | 2.7% |
-0.7% |
-10.5% |
You may also like the below Video Courses